Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-12

FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for EVEKEO (amphetamine sulfate) from Azurity Pharmaceuticals, Inc., resulting in an updated labeling for the produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EVEKEO (AMPHETAMINE SULFATE)

Snippet

SUPPL AP for EVEKEO (AMPHETAMINE SULFATE)